Find all School-related info fast with the new School-Specific MBA Forum

It is currently 01 Oct 2014, 06:45

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

In countries in which new-life sustaining drugs cannot be

  Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:
3 KUDOS received
Manager
Manager
avatar
Joined: 15 Nov 2006
Posts: 223
Location: Ohio
Followers: 1

Kudos [?]: 12 [3] , given: 0

In countries in which new-life sustaining drugs cannot be [#permalink] New post 18 Mar 2007, 19:11
3
This post received
KUDOS
1
This post was
BOOKMARKED
00:00
A
B
C
D
E

Difficulty:

(N/A)

Question Stats:

90% (02:13) correct 10% (02:04) wrong based on 312 sessions
In countries in which new-life sustaining drugs cannot be patented, such drugs are sold at widely affordable prices; those same drugs, where patented, command premium prices because the patents shieldpatent-holding company from competitors. These facts show that future access to new life sustaining drugs can be improved if the practice of granting patents on newly developed life-sustaining drugs were to be abolished everywhere.

Which of the following, if true, most seriously weakens the arguement?
A) In countries in which life-sustaining drugs cannot be patented, their manufacturer is neverthless a profitable enterprise.
b) Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations
C) In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which the drugs themselves cannot be patented.
D) Pharmaceutical companies can afford the research that go into the development of new drugs only if patents allow them to earn high profits.
E) Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents.
Director
Director
avatar
Joined: 24 Aug 2006
Posts: 754
Location: Dallas, Texas
Followers: 5

Kudos [?]: 29 [0], given: 0

 [#permalink] New post 18 Mar 2007, 22:42
D !
_________________

"Education is what remains when one has forgotten everything he learned in school."

Senior Manager
Senior Manager
avatar
Joined: 27 Jul 2006
Posts: 299
Followers: 1

Kudos [?]: 7 [0], given: 0

 [#permalink] New post 19 Mar 2007, 06:34
One more D
VP
VP
User avatar
Joined: 06 Feb 2007
Posts: 1024
Followers: 19

Kudos [?]: 117 [0], given: 0

Reviews Badge
 [#permalink] New post 19 Mar 2007, 07:05
Yeah, D makes a lot of sense...
Manager
Manager
avatar
Joined: 28 Feb 2007
Posts: 198
Location: California
Followers: 2

Kudos [?]: 4 [0], given: 0

Re: CR-Patented Drugs [#permalink] New post 19 Mar 2007, 07:12
nitinneha wrote:
In countries in which new-life sustaining drugs cannot be patented, such drugs are sold at widely affordable prices; those same drugs, where patented, command premium prices because the patents shieldpatent-holding company from competitors. These facts show that future access to new life sustaining drugs can be improved if the practice of granting patents on newly developed life-sustaining drugs were to be abolished everywhere.

Which of the following, if true, most seriously weakens the arguement?
A) In countries in which life-sustaining drugs cannot be patented, their manufacturer is neverthless a profitable enterprise.
b) Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations
C) In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which the drugs themselves cannot be patented.
D) Pharmaceutical companies can afford the research that go into the development of new drugs only if patents allow them to earn high profits.
E) Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents.


D
Manager
Manager
avatar
Joined: 15 Nov 2006
Posts: 223
Location: Ohio
Followers: 1

Kudos [?]: 12 [0], given: 0

 [#permalink] New post 20 Mar 2007, 16:15
OA is D.

Could someone please elaborate on why C is wrong?

Also, in first sentence, it clearly says that in some countries where drug is not patented, it sells for less.

nitin
Manager
Manager
avatar
Joined: 26 Feb 2007
Posts: 93
Followers: 1

Kudos [?]: 7 [0], given: 0

 [#permalink] New post 20 Mar 2007, 16:28
In countries in which new-life sustaining drugs cannot be patented, such drugs are sold at widely affordable prices; those same drugs, where patented, command premium prices because the patents shieldpatent-holding company from competitors. These facts show that future access to new life sustaining drugs can be improved if the practice of granting patents on newly developed life-sustaining drugs were to be abolished everywhere.

Which of the following, if true, most seriously weakens the arguement?
A) In countries in which life-sustaining drugs cannot be patented, their manufacturer is neverthless a profitable enterprise.
b) Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations
C) In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which the drugs themselves cannot be patented.
D) Pharmaceutical companies can afford the research that go into the development of new drugs only if patents allow them to earn high profits.
E) Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents.

D for me as argument is weakened if it cosiders the cost of research and high cost, in countries where patent is legal, contribute to the research
Manager
Manager
avatar
Joined: 26 Feb 2007
Posts: 93
Followers: 1

Kudos [?]: 7 [0], given: 0

 [#permalink] New post 20 Mar 2007, 16:30
C is wrong as it doesn't counter the point that abolishing patent might lead to stagnation in research and hence no new life saving drugs, which the author is very concerned about.
Manager
Manager
avatar
Joined: 26 Feb 2007
Posts: 115
Followers: 1

Kudos [?]: 1 [0], given: 0

 [#permalink] New post 20 Mar 2007, 20:49
One and only D.
1 KUDOS received
Manager
Manager
avatar
Joined: 22 Dec 2006
Posts: 77
Followers: 1

Kudos [?]: 3 [1] , given: 0

 [#permalink] New post 23 Mar 2007, 03:17
1
This post received
KUDOS
D as C only supports the arguement for unpatended drugs.
Verbal Forum Moderator
Verbal Forum Moderator
User avatar
Status: Flying over the cloud!
Joined: 16 Aug 2011
Posts: 818
Location: Viet Nam
Concentration: International Business, Marketing
Schools: Ross '17, Duke '16
GMAT Date: 06-06-2014
GPA: 3.07
Followers: 41

Kudos [?]: 223 [0], given: 43

GMAT ToolKit User Premium Member CAT Tests
Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 09 Dec 2011, 01:53
+1 D
_________________

Rules for posting in verbal gmat forum, read it before posting anything in verbal forum
Giving me + 1 kudos if my post is valuable with you :)

The more you like my post, the more you share to other's need

CR: Focus of the Week: Must be True Question

Manager
Manager
avatar
Joined: 08 Aug 2011
Posts: 203
GPA: 3.5
Followers: 1

Kudos [?]: 10 [0], given: 51

Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 07 Jan 2012, 22:03
D it is.If patents are banned then future research for more life saving drugs will also be hampered hence patents should not be banned.
3 KUDOS received
Intern
Intern
avatar
Joined: 13 Nov 2010
Posts: 42
Followers: 0

Kudos [?]: 13 [3] , given: 2

Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 23 Apr 2012, 04:44
3
This post received
KUDOS
In countries in which new-life sustaining drugs cannot be patented, such drugs are sold at widely affordable prices; those same drugs, where patented, command premium prices because the patents shield patent-holding company from competitors. These facts show that future access to new life sustaining drugs can be improved if the practice of granting patents on newly developed life-sustaining drugs were to be abolished everywhere. Which of the following, if true, most seriously weakens the argument?
A. In countries in which life-sustaining drugs cannot be patented, their manufacturer is nevertheless a profitable enterprise.
B. Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations.
C. In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which the drugs themselves cannot be patented.
D. Pharmaceutical companies can afford the research that go into the development of new drugs only if patents allow them to earn high profits.
E. Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents.



Explanation:

The argument states that due to patents the profits of pharmaceutical manufacturing companies won't be earn as much profits as in case of no patents ,so if there is no patents there is more profits and with patents less profit and the conclusion is by abolition of patents the future access to life saving drugs can improve and companies would earn more profit , so we should attack the conclusion by saying that with patents the companies can earn more profit or without patents the access to life saving drugs would decrease and companies would earn less profit . By looking closely we can see that option d states that if govt promises to grant patents only companies develops new life saving drugs as a result companies would earn more profit. i rejected option c because option c states that only drug manufacturing process can be patented and not drugs so the argument anywhere does not states that drug manufacturing process can be patented and not drugs so we can reject option c on this basis.


if you like this give me +1 kudos
McCombs Thread Master
avatar
Joined: 24 Sep 2012
Posts: 129
Location: India
Concentration: General Management, Strategy
GMAT 1: 710 Q48 V39
WE: Project Management (Energy and Utilities)
Followers: 2

Kudos [?]: 31 [0], given: 22

CAT Tests
Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 24 Feb 2013, 07:56
why is B not corect can somebody throw a light on this??
_________________

My GMAT debrief

greatness is not about possessing talent but about having the discipline to summon that talent whenever needed!!!


Please Kudos my post if it helped you!!

Expert Post
e-GMAT Representative
User avatar
Joined: 02 Nov 2011
Posts: 1792
Followers: 1276

Kudos [?]: 3591 [0], given: 185

Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 25 Feb 2013, 21:42
Expert's post
jkaustubh wrote:
why is B not corect can somebody throw a light on this??


Hi,

b) Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations

This option only tells that most of the countries which currently do not grant patents have large populations. So what? The option doesn't tell whether people have easy access to the life-saving drugs in this country - which is the essence of the conclusion.

Thanks,
Chiranjeev
_________________

https://www.youtube.com/watch?v=WeT9_Wr0DlI&feature=youtu.be

Manager
Manager
avatar
Joined: 19 Aug 2012
Posts: 64
Followers: 1

Kudos [?]: 12 [0], given: 9

Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 10 Apr 2013, 04:39
can anyone explain all the option choices..

Thanx in advance
_________________

giving kudos is the best thing you can do for me..

6 KUDOS received
Current Student
User avatar
Status: Attending Duke in May!
Joined: 07 Jan 2013
Posts: 32
Location: United States (NC)
Concentration: Leadership, Strategy
GMAT 1: 640 Q42 V35
Followers: 0

Kudos [?]: 21 [6] , given: 18

Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 16 Apr 2013, 22:58
6
This post received
KUDOS
nitinneha wrote:
In countries in which new-life sustaining drugs cannot be patented, such drugs are sold at widely affordable prices; those same drugs, where patented, command premium prices because the patents shieldpatent-holding company from competitors. These facts show that future access to new life sustaining drugs can be improved if the practice of granting patents on newly developed life-sustaining drugs were to be abolished everywhere.

Which of the following, if true, most seriously weakens the arguement?
A) In countries in which life-sustaining drugs cannot be patented, their manufacturer is neverthless a profitable enterprise.
b) Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations
C) In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which the drugs themselves cannot be patented.
D) Pharmaceutical companies can afford the research that go into the development of new drugs only if patents allow them to earn high profits.
E) Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents.


The key to solving CR questions is to fully understand the conclusion. Always find the conclusion.

The conclusion here is the final sentence: These facts show that future access to new life sustaining drugs can be improved if the practice of granting patents on newly developed life-sustaining drugs were to be abolished everywhere.

In all weaken/strengthen arguments the conclusion contains the main point that can be attacked or supported. So since we want to weaken the argument, we're looking for the answer that most successfully attacks this conclusion.

A.) In countries in which life-sustaining drugs cannot be patented, their manufacturer is neverthless a profitable enterprise. This statement somewhat strengthens the conclusion, if companies without patents are profitable, the patents could not be necessary.

B.) Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations This statement neither weakens or strengthens the conclusion, it merely points out that the non-patent granting countries are ones with large populations.

C.) In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which the drugs themselves cannot be patented. This is the trap answer. There is logic behind this answer that could potentially weaken the argument. You probably said to yourself, "if we don't necessarily patent the drug itself, but the manufacturing process instead, it could (key word here) lead to the monopoly-type environment that the author wants to avoid!" But, the reverse is also true. Try not to get sucked in. There are many ways to manufacture drugs and even if one way is patented it can still be possible to reach the non-patent Utopia (through multiple manufacturing processes) that author is hoping for. This answer is close, but not quite up to snuff.

D.) Pharmaceutical companies can afford the research that go into the development of new drugs only if patents allow them to earn high profits. BINGO! This answer hits the conclusion right in the sweet spot! The Companies need the profits that the patents provide to enable the research to create the "future access to new life sustaining drugs" that the author talks about directly the conclusion argument. No HIGH (key word) profits = no new drugs. This kills the author's argument.

E.) Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents. This statement actually strengthens the argument of the author. If patent granting countries banned their supposedly cheaper imports, it would further increase the profits on the companies that are granted patents that the author says need to be eliminated. This is the opposite of what we're looking for.
Intern
Intern
avatar
Joined: 05 Jan 2013
Posts: 3
Location: United States (CA)
Concentration: General Management, Technology
GPA: 3.5
Followers: 0

Kudos [?]: 5 [0], given: 13

Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 19 Aug 2013, 23:25
Took me a while to understand this.

Conclusion: Future access to drugs can be improved if NO patents.
Weaken: Pharma companies can only afford to develop these drugs b/c patents make them $$.

(D) weakens because if pharma didn't have patents, they wouldn't have the $$ to develop new drugs.
Manager
Manager
User avatar
Joined: 10 Mar 2013
Posts: 201
Followers: 0

Kudos [?]: 10 [0], given: 1782

CAT Tests
Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 03 May 2014, 17:11
Honestly, all of the answers seem bad to me, because none of them seem to affect the conclusion of "access" to new drugs. However, D is the best answer.
Intern
Intern
avatar
Joined: 19 May 2014
Posts: 4
Followers: 0

Kudos [?]: 0 [0], given: 4

Re: In countries in which new-life sustaining drugs cannot be [#permalink] New post 19 May 2014, 03:50
Looks like D is the best choice :- more profit and more money for R & D.
Re: In countries in which new-life sustaining drugs cannot be   [#permalink] 19 May 2014, 03:50
    Similar topics Author Replies Last post
Similar
Topics:
Experts publish their posts in the topic which of the following cannot be the median tejal777 3 07 Jul 2009, 04:25
Which of the following cannot be the greatest common alimad 1 18 May 2007, 04:49
If n is an integer, which of the following CANNOT be a lan583 6 05 Oct 2006, 12:04
Which of the following CANNOT be the median of the three buckkitty 3 24 May 2006, 15:43
If n is an integer, which of the following CANNOT be a vprabhala 6 24 Jan 2005, 18:29
Display posts from previous: Sort by

In countries in which new-life sustaining drugs cannot be

  Question banks Downloads My Bookmarks Reviews Important topics  

Go to page    1   2    Next  [ 21 posts ] 



GMAT Club MBA Forum Home| About| Privacy Policy| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group and phpBB SEO

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.